0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Gut & Microbiome Human Health Effects Marine & Wildlife Policy & Risk Sign in to save

Multi-Omics Platforms Reveal Synergistic Intestinal Toxicity in Tilapia from Acute Co-Exposure to Polystyrene Microplastics, Sulfamethoxazole, and BDE153

International Journal of Molecular Sciences 2025 3 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 58 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Yao Zheng, Jiajia Li, Jiajia Li, Jiajia Li, Jiajia Li, Lihong Li, Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu Yao Zheng, Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu Gangchun Xu

Summary

Researchers exposed tilapia to polystyrene microplastics combined with an antibiotic and a flame retardant to study their combined effects on gut health. Using multiple analytical methods, they found that the pollutant mixtures caused significant intestinal damage, including reduced immune activity, disrupted lipid metabolism, and decreased goblet cell density. The study suggests that microplastics and co-occurring contaminants can work together to amplify harmful effects on fish digestive systems.

Polymers
Body Systems

Polystyrene microplastic (MP) and its co-existing contaminants may exert different toxic effects on its surrounding aquatic organisms. In order to detect the intestinal harmful responses, tilapia were subjected to exposure with 75 nm of MPs, 100 ng·L<sup>-1</sup> of sulfamethoxazole (SMZ), 5 ng·L<sup>-1</sup> of BDE153, and combinations thereof over periods of 2, 4, and 8 days. Enzymatic assays, transcriptomics, proteomics, and metabolomics were employed to evaluate intestinal histopathological effects. Results showed that significant reductions were observed in ATP, ROS, SOD, EROD, lipid metabolism-related enzymes, pro-inflammatory cytokines (TNFα and IL-1β), and apoptosis marker caspase 3 across all groups at day 8. Histological evaluation revealed diminished goblet cell density, with distinct vacuole formation in the BDE153+MPs group. KEGG pathway analysis highlighted disruptions in endocytosis, MAPK signaling, phagosome formation, and actin cytoskeleton regulation. Proteomic findings indicated notable enrichment in endocytosis (decreased sorting nexin-2; increased Si:dkey-13a21.4), MAPK/PPAR signaling, protein processing in the endoplasmic reticulum (Sec61 subunit gamma), and cytoskeletal modulation (reduced fibronectin; elevated activation peptide fragment 1), with or without SMZ and BDE153. Metabolomic profiling showed significant alterations in ABC transporters, aminoacyl-tRNA biosynthesis, protein digestion and absorption, and linoleic acid metabolism. In summary, these findings suggest that BDE153 and MPs synergistically exacerbate intestinal damage and gene/protein expression over time, while SMZ appears to exert an antagonistic, mitigating effect.

Sign in to start a discussion.

Share this paper